AC
a16z Capital Management, L.L.C.
Sector-focusedMomentum followerQuality / disciplined sizing
Total reported value
$1.3B
Reporting period: 2026-03-31 · Number of holdings: 16
a16z Capital Management, L.L.C. disclosed 16 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $1.3B and a quarterly turnover rate of 40.1%.
Personality snowflake
- Concentration
- 70.93
- Portfolio Stability
- 40.13
- Momentum/Contrarian
- 100
- Sector conviction
- 100
- Diversification
- 32
- Sizing Uniformity
- 86
Recent moves
Trim FIG
-1.4% -$268.6M
Add NAUT
0.0% $34.1M
Add ERAS
0.0% $35.7M
Add RVMD
0.0% $16.2M
Add BIOA
0.0% $12.5M
Trim OMDA
-33.3% -$25.6M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NAVN | Navan Inc-cl A | Stock-Other | 28.95% | -0.45% | +3.76% | |
| 2 | FIG | Figma Inc-cl A | Stock-Other | 26.23% | -12.20% | -1.45% | |
| 3 | META | Meta Platforms Inc-class A | Stock-Comm Services | 9.42% | +0.54% | — | |
| 4 | RVMD | Revolution Medicines INC | Stock-Healthcare | 6.94% | +2.30% | — | |
| 5 | NAUT | Nautilus Biotechnology INC | Stock-Other | 5.31% | +3.13% | — | |
| 6 | XYZ | Block INC | Stock-Financials | 4.74% | +0.55% | — | |
| 7 | BIOA | Bioage Labs INC | Stock-Other | 4.38% | +1.59% | — | |
| 8 | MAZE | Maze Therapeutics INC | Stock-Other | 3.94% | -0.52% | — | |
| 9 | ERAS | Erasca INC | Stock-Other | 3.59% | +2.92% | — | |
| 10 | DMRA | Damora Therapeutics INC | Stock-Other | 2.48% | +2.48% | NEW | |
| 11 | OMDA | Omada Health INC | Stock-Other | 2.25% | -1.21% | -33.33% | |
| 12 | CAMP | Camp4 Therapeutics CORP | Stock-Other | 0.73% | -0.09% | — | |
| 13 | AKTS | Aktis Oncology INC | Stock-Other | 0.58% | +0.58% | NEW | |
| 14 | BTGO | Bitgo Holdings Inc-cl A | Stock-Other | 0.42% | +0.42% | NEW | |
| 15 | DNA | Ginkgo Bioworks Holdings INC | Stock-Other | 0.05% | -0.01% | — | |
| 16 | ✓ | Heritage Distilling Hldg | Stock-Other | — | — | NEW |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 16 | $1.3B | 40 | |
| 2025-12-31 | 13 | $1.6B | 61 | |
| 2025-09-30 | 11 | $1.4B | 100 | |
| 2025-06-30 | 10 | $312.9M | 0 | |
| 2025-03-31 | 13 | $700.9M | 0 | |
| 2024-12-31 | 12 | $745.3M | 0 | |
| 2024-09-30 | 13 | $1.1B | 0 | |
| 2024-06-30 | 13 | $1.2B | 0 | |
| 2024-03-31 | 13 | $1.4B | 0 | |
| 2023-12-31 | 16 | $1.6B | 0 |
Holding changes this quarter
a16z Capital Management, L.L.C.'s most significant position changes for 2026-03-31: New buy: Damora Therapeutics INC (DMRA); New buy: Aktis Oncology INC (AKTS); New buy: Bitgo Holdings Inc-cl A (BTGO); Sold out: Heritage Commerce CORP (XHC); New buy: Heritage Distilling Hldg.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NAUT | Nautilus Biotechnology INC | +3.1% | — | Unchanged |
| 2 | ERAS | Erasca INC | +2.9% | — | Unchanged |
| 3 | RVMD | Revolution Medicines INC | +2.3% | — | Unchanged |
| 4 | BIOA | Bioage Labs INC | +1.6% | — | Unchanged |
| 5 | XYZ | Block INC | +0.6% | — | Unchanged |
| 6 | META | Meta Platforms Inc-class A | +0.5% | — | Unchanged |
| 7 | DNA | Ginkgo Bioworks Holdings INC | 0% | — | Unchanged |
| 8 | CAMP | Camp4 Therapeutics CORP | -0.1% | — | Unchanged |
| 9 | NAVN | Navan Inc-cl A | -0.5% | +3.76% | Add |
| 10 | MAZE | Maze Therapeutics INC | -0.5% | — | Unchanged |
| 11 | OMDA | Omada Health INC | -1.2% | -33.33% | Trim |
| 12 | FIG | Figma Inc-cl A | -12.2% | -1.45% | Trim |
| 13 | DMRA | Damora Therapeutics INC | — | NEW | New buy |
| 14 | AKTS | Aktis Oncology INC | — | NEW | New buy |
| 15 | BTGO | Bitgo Holdings Inc-cl A | — | NEW | New buy |
| 16 | XHC | Heritage Commerce CORP | — | EXIT | Sold out |
| 17 | ✓ | Heritage Distilling Hldg | — | NEW | New buy |
FAQ
What is a16z Capital Management, L.L.C. and what type of investor is it?
a16z Capital Management, L.L.C. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $1.3B, spread across 16 disclosed positions.
What are a16z Capital Management, L.L.C.'s largest equity positions?
Based on the latest 13F filing, a16z Capital Management, L.L.C.'s top holdings by market value are:
1. Navan Inc-cl A (NAVN) — $373.6M (28.9%)
2. Figma Inc-cl A (FIG) — $338.5M (26.2%)
3. Meta Platforms Inc-class A (META) — $121.6M (9.4%)
4. Revolution Medicines INC (RVMD) — $89.6M (6.9%)
5. Nautilus Biotechnology INC (NAUT) — $68.5M (5.3%)
What changes did a16z Capital Management, L.L.C. make in its most recent portfolio filing?
In the latest reported quarter, a16z Capital Management, L.L.C. made 8 notable position adjustments: 4 new positions were initiated, 1 existing holdings were added to, 2 positions were partially reduced, and 1 were completely exited. The largest of these moves: New buy: Damora Therapeutics INC (DMRA); New buy: Aktis Oncology INC (AKTS); New buy: Bitgo Holdings Inc-cl A (BTGO); Sold out: Heritage Commerce CORP (XHC); New buy: Heritage Distilling Hldg
What sectors does a16z Capital Management, L.L.C. focus on?
a16z Capital Management, L.L.C. is concentrated in the following sectors based on its current disclosed equity portfolio:
• Communication Services: 44.6%
• Health Care: 32.9%
• Financials: 22.5%